Introduction | 25 1 Patient decision aids Patient Decision Aids (PDAs) are instrumental in facilitating Shared Decision Making (SDM), offering a structured approach for patients and healthcare providers to engage in informed discussions about treatment options. PDAs are designed to present evidencebased information about the risks, benefits, and alternatives of treatments, helping patients to make decisions that align with their personal values and preferences56. The use of PDAs has been associated with improved knowledge, reduced decisional conflict, and greater satisfaction with the decision-making process. Moreover, PDAs support the implementation of clinical practice guidelines by ensuring that patient choices are informed by the best available evidence57,58. Despite benefits, challenges like time constraints and health literacy hinder widespread adoption. Discrepancies exist between positive outcomes and real-world implementation, highlighting a gap between evidence and practice59. Additionally, PDAs’ availability and efficacy vary, necessitating adherence to International Patient Decision Aid Standards (IPDAS) for evidence-based, patient-centered development60. Challenges include managing costs, achieving stakeholder consensus, involving a multidisciplinary team, clinical implementation, and keeping PDAs updated58,61. Addressing these demands careful planning, collaboration, and continuous evaluation. There’s a noted discrepancy between the positive outcomes associated with PDA use and the actual implementation of these tools in everyday clinical settings, underscoring a gap between evidence and practice58,61. The development of Patient Decision Aids (PDAs) adheres to the International Patient Decision Aid Standards (IPDAS) criteria60, ensuring evidence-based content, clarity, and patient-centeredness. However, challenges arise, including managing costs effectively, achieving consensus among stakeholders, involving a multidisciplinary team, implementing the PDA into clinical practice seamlessly, and keeping it up to date with evolving evidence and patient preferences. Overcoming these hurdles requires careful planning, collaboration, and continuous evaluation processes. In head and neck oncology, the lack of PDAs underscores a pressing necessity for tailored tools that address the distinctive decision-making challenges faced by patients. Bridging this gap is imperative for propelling patient-centered care forward in oncology, enabling patients to be fully informed and empowered in their treatment decisions.
RkJQdWJsaXNoZXIy MTk4NDMw